A carregar...
4CPS-038 Initial experience with the use of pcsk9-inhibitors in the real-world clinical practice
BACKGROUND: New lipid-lowering therapies with excellent results on LDL cholesterol (LDL-C) levels came to market at more than five times the cost of the most effective statin regimen. We need strategies to put these treatments into practice and ensure their cost effectiveness. PURPOSE: In December 2...
Na minha lista:
| Publicado no: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535474/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.129 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|